SEBI seeks public comments on report submitted by the working group on issues concerning proxy advisors
SEBI.gov.in

Sunil Sanghai is part of the working group constituted by SEBI on issues concerning proxy advisors

GSK Plc to divest Chiron Behring Vaccines Private Limited (CBVPL), GSK’s Rabies vaccine manufacturing business for India & select other emerging markets to Bharat Biotech India Limited (BBIL)
https://www.bharatbiotech.com/

NovaDhruva acted as an Advisor to GSK Plc

GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever
GSK.com

NovaDhruva acted as an Advisor to GSK Plc

Impact on Capital Markets
FICCI

Sunil Sanghai, founder and CEO of NovaDhruva reflects on Impact of Capital Markets at the CAPAM 2018 held by FICCI

Odisha Investor Summit
Orissadiary.com

Sunil Sanghai on investment opportunity through private equity

Private Equity – An important source of funding for Indian Companies
Livemint

Sunil Sanghai on success of private equity in India

NovaDhruva on the Block
CNBC TV-18

NovaDhruva founders caught up with Nisha Poddar of CNBC to discuss the new investment bank on the block NovaDhruva

1 2 3